The much anticipated World Trade Organisation meeting is set to go ahead in Qatar's capital Doha afte...
The FT points out that the meeting will become the second major meeting of heads of state following the APEC conference just ended in Shanghai.
Many countries are eager to start another round of trade talk negotiations following recent terrorist events - if only to show that the world will continue to function largely as normal - but there are other reasons too, such as China's forthcoming official entry into the organisation.
The FT says the trade negotiations will also be needed to deal with issues such as Canada's decision over the weekend to halt patent protection of the most popular Anthrax antibiotic Cipro.
The manufacturer of Cipro, German agro-chemical giant Bayer, says it has more than enough tablets to meet the Canadian government's emergency purchase order, but the Canadians disagree, and point to emergency laws that give it the right to over-ride patent concerns.
This all comes in reaction to the war in Afghanistan and the spreading fear of bio-terrorism in the wake of Anthrax cases in the US and elsewhere.
Canada has just sent more troops to support the war against Afghanistan, and may feel that as a result it has made itself more of a direct target for reprisals.
The Times takes time out today to review tomorrow's expected stormy shareholders meeting ahead of the demerger of BT's wireless operations - now under the name mmO2.
Unions at the troubled telecoms carrier say the demerger plans will leave the rump BT - in charge of fixed landlines - ripe for a takeover as the company will be saddled with debts, while the new wireless company will start life out with a relatively clean balance sheet.
Many shareholders too will be paying particular attention to the meeting, as they were already forced to go to the High Court to make the company pay attention to their votes.
Staying invested could prove lucrative
Consider lasting powers of attorney
Less environment, more governance threatens to undermine firms' green credentials
Evidence your compliance